CHOLLEY PhytocellBooster is ideal for smoothening wrinkles and eliminating the signs of aging or fatigue. It is a perfect product in many situations, such as after waking up in the morning, an exhausting day at work, and prior to attending a business meeting or party.

CHOLLEY Phytocell Booster instantly reduces wrinkles and imparts a lifted and younger-looking appearance to the skin. With Swiss guarantee of quality and excellence, the stem cells serum is clinically tested and found to be suitable for all skin type and complexions.

To exploit the power of IC-RAMP technology and Swiss stem cells technology, use CHOLLEY Phytocell Cream in combination with CHOLLEY Phytocell Booster. They provide your skin with full spectrum, day and night abti-aging care.

For best results, in morning and at night, apply CHOLLEY Phytocell Booster on the face, neck and dcollet. When the product is fully absorbed, complete the treatment with the application of CHOLLEY Phytocell Cream. It is the perfect Anti-aging and Antioxidant program.

Read this article:
Buy Serum Stem Cells Skin Care Products | CHOLLEY

Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth. In addition, in many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive. When a stem cell divides, each new cell has the potential either to remain a stem cell or become another type of cell with a more specialized function, such as a muscle cell, a red blood cell, or a brain cell.

Stem cells are distinguished from other cell types by two important characteristics. First, they are unspecialized cells capable of renewing themselves through cell division, sometimes after long periods of inactivity. Second, under certain physiologic or experimental conditions, they can be induced to become tissue- or organ-specific cells with special functions. In some organs, such as the gut and bone marrow, stem cells regularly divide to repair and replace worn out or damaged tissues. In other organs, however, such as the pancreas and the heart, stem cells only divide under special conditions.

Until recently, scientists primarily worked with two kinds of stem cells from animals and humans: embryonic stem cells and non-embryonic "somatic" or "adult" stem cells. The functions and characteristics of these cells will be explained in this document. Scientists discovered ways to derive embryonic stem cells from early mouse embryos more than 30 years ago, in 1981. The detailed study of the biology of mouse stem cells led to the discovery, in 1998, of a method to derive stem cells from human embryos and grow the cells in the laboratory. These cells are called human embryonic stem cells. The embryos used in these studies were created for reproductive purposes through in vitro fertilization procedures. When they were no longer needed for that purpose, they were donated for research with the informed consent of the donor. In 2006, researchers made another breakthrough by identifying conditions that would allow some specialized adult cells to be "reprogrammed" genetically to assume a stem cell-like state. This new type of stem cell, called induced pluripotent stem cells (iPSCs), will be discussed in a later section of this document.

Stem cells are important for living organisms for many reasons. In the 3- to 5-day-old embryo, called a blastocyst, the inner cells give rise to the entire body of the organism, including all of the many specialized cell types and organs such as the heart, lungs, skin, sperm, eggs and other tissues. In some adult tissues, such as bone marrow, muscle, and brain, discrete populations of adult stem cells generate replacements for cells that are lost through normal wear and tear, injury, or disease.

Given their unique regenerative abilities, stem cells offer new potentials for treating diseases such as diabetes, and heart disease. However, much work remains to be done in the laboratory and the clinic to understand how to use these cells for cell-based therapies to treat disease, which is also referred to as regenerative or reparative medicine.

Laboratory studies of stem cells enable scientists to learn about the cells essential properties and what makes them different from specialized cell types. Scientists are already using stem cells in the laboratory to screen new drugs and to develop model systems to study normal growth and identify the causes of birth defects.

Research on stem cells continues to advance knowledge about how an organism develops from a single cell and how healthy cells replace damaged cells in adult organisms. Stem cell research is one of the most fascinating areas of contemporary biology, but, as with many expanding fields of scientific inquiry, research on stem cells raises scientific questions as rapidly as it generates new discoveries.

I.Introduction|Next

Follow this link:
Stem Cell Basics I. | stemcells.nih.gov

In simpler times, skincare choices were slotted by agetwenties, thirties, fortiesor skin type, that is, oily, dry or combination. Night creams signalled a milestone, an anti-ageing ritual you transited to once you turned forty. Not anymore. A new generation of night creams and hybrids in a jar are challenging the norm. And millennials, more concerned than ever before about the state of their skin, are discovering a range of choices on offer. Retinols, ferulic acid, hyaluronic acid, ceramides, phospholipids, stem cells, biomimetic peptides, arbutin are just some of the ingredients you find in night creams, and you have to choose keeping a combination of factors in mind, says Dr Malavika Kohli, a Mumbai-based celebrity dermatologist.

Your skin could be older than your age, at any ageAs experts repeatedly tell us, there are two kinds of ageingintrinsic and extrinsic. The first is caused by the ticking of the clock and cant be reversed, though perhaps, can be slowed down. The second is caused by factors we all face dailyharsh sun, pollutants and air conditioning, which can cause skin to age faster on the surface. We have lifestyle habits we find hard to kick like smoking and drinking. I wont even begin to talk of 4pm sugar cravings. Over-exercising and yo-yo dieting are an easy way to get sagging skinyou dont have to wait till you reach forty.

The rhythm of the nightThe day is for protection and coverage, and sunscreens, BB creams, CC creams work hard to battle environmental factors. But the night is for more intensive repair, undisturbed. The night signals a time of rest and restoration as your cells tend to be more relaxed and receptive. If you have problem skin, the night is the time to let a good anti-blemish cream go to work. If your skin is dehydrated, then a moisturising cream will deliver the benefits best at night. Many star ingredients like retinol and vitamin C, in potent form, work best out of the sun.

Cream versus serum versus lotionDo creams score over lotions? New generation night creams are often oil-free, light and easily absorbedall the things you looked for in a lotion. Thanks to their creamy nature, they texturise skin better leaving it silky and soft. Mousse, cream-gels and moisture-whipped creams are blurring the definition of traditional creams and lotions. Serums are specifically targeted to work at the cellular level and dont deliver overall surface moisture, so use a combination of that and a cream as you get older.

Understand your skinKnowing your skin type is important, but so is understanding your skin condition. Dry skin for example, says Dr Kohli, lacks sebum or oil, while dehydrated skin lacks water, but both indicate poor barrier function.

If your skin is very dehydrated on the surface, Este Edit by Este Lauders Pink Peony Overnight Water Pack targets all skin types. It gives skin an antioxidant boost with extracts of goji berry, blueberry and cranberry in a water-based gel. Garnier SkinActive Moisture Bomb, with amla and plant serums, is targeted at dry and sensitive skin. For more intense deep moisturisation try, a cream with hyaluronic acid like Revitalift Laser X3 Night Cream Mask from LOral Paris.

For skin that is irritated and sun-damaged, a cocktail of antioxidants, peptides and vitamins will help. Olay Regenerist Advanced Anti-Ageing Revitalizing Night Skin Cream has an amino-peptide complex that gets the skin into healing mode while you snooze.

Just Herbs Blemfree Anti Blemish Night Cream is SLS, petrochemical and paraben-free and will not irritate damaged skin further. It targets sun spots, uneven and patchy skin with organic sunflower oil.

Dull skin with pigmentation indicates pore-clogging debris accumulation and slow cell turnover. A cream with salicylic acid will provide much-needed but gentle exfoliation at night. Clinique Turnaround Overnight Revitalising Moisturizer is non-acnegenic and has both salicylic acid and beta hydroxy acid to speed up exfoliation.

Kama Ayurvedas Rejuvenating And Brightening Ayurvedic Night Cream has saffron, aloe vera, liquorice and manjistha (a blood purifier), which work to soothe skin and improve cell turnover.

Early crows feet and fine lines will benefit from retinoid-based creams for long-lasting results. Neutrogena Rapid Wrinkle Repair Night Moisturizer with retinol is non-greasy yet promises deep action. For a targeted solution, Yves Rocher Serum Vegetal Wrinkles & Firmness Targeted Filler Eyes And Lips works specifically on crows feet and fine lines around the eye. It can also be used under make-up in the day but use it at night for best results.

The Body Shops Pomegranate Firming Night Cream has organic oil of pomegranate and pomegranate peel, which aresupposed to deliver retinol-like resultspomegranates are a rich source of antioxidants as well.

Natural, organic, ayurvedic or chemicalfor all night creams to deliver results, wait four to six weeks. But most importantly choosing right, investing in the right skin care routine and maintaining it will be the best thing you can do, says Dr Kohli. Make the commitment. You skin will thank you for this.

Take your pick from our edit below:

Este Edit by Este Lauders Pink Peony Overnight Water Pack, Rs 3,202

Garnier SkinActive Moisture Bomb, Rs 1,088

LOral Paris Revitalift Volume Filler Night Cream, Rs 1,450

Olay Regenerist Advanced Anti-Ageing Revitalizing Night Skin Cream, Rs 1,399

Just Herbs Blemfree Anti Blemish Night Cream, Rs 895

Clinique Turnaround Overnight Revitalising Moisturizer, Rs 2,626

Kama Ayurveda Rejuvenating And Brightening Ayurvedic Night Cream, Rs 1,950

Neutrogena Rapid Wrinkle Repair Night Moisturizer, Rs 1,199

Yves Rocher Serum Vegetal Wrinkles & Firmness Targeted Filler Eyes And Lips, Rs 1,400

The Body Shops Pomegranate Firming Night Cream, Rs 1,696

Read more:
How to choose the right night cream for your skin - VOGUE India

Cellular Renovation

Why build something from the ground up when one can just renovate an already existing structure? Essentially, thats what researchers from the University of Washington School of Medicine in St. Louis had in mind when they developed a method for transforming adult human skin cells into motor neurons in a lab. They published their work in the journal Cell Stem Cell.

In this study, we only used skin cells from healthy adults ranging in age from early 20s to late 60s, senior author Andrew S. Yoo said in a press release. Our research revealed how small RNA molecules can work with other cell signals called transcription factors to generate specific types of neurons, in this case motor neurons. In the future, we would like to study skin cells from patients with disorders of motor neurons. Our conversion process should model late-onset aspects of the disease using neurons derived from patients with the condition.

They did this by exposing skin cells in a lab to certain molecular signals usually found at high levels in the human brain. They focused on two short snippets of RNA: microRNAs (mRNAs) called miR-9 and miR-124, which are involved in repurposing the genetic instructions of the cell. These mRNAs, combined with certain transcription factors, successfully turned skin cells into spinal cord motor neurons within just 30 days. These new cells closely resembled normal mouse motor neurons in terms of which genes were turned on and off, and how they functioned.

Usually, when researchers find ways to replace damaged cells or organs, they resort to using stem cells. In particular, they use embryonic stem cells (a type of pluripotent stem cells) to grow the cells or organs needed.

While this type of stem cell has the potential to grow into whatever adult cell type is needed, the procedure carries some ethical concerns. In bypassing a stem cell phase, the new cell transformation technique doesnt have any of these ethical issues.

Keeping the original age of the converted cells can be crucial for studying neurodegenerative diseases that lead to paralysis, such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy, the condition the new research focused on. In particular, researchers hope that it could enhance the understanding of these diseases in order to improve regenerative medicine.

Going back through a pluripotent stem cell phase is a bit like demolishing a house and building a new one from the ground up, Yoo explained. What were doing is more like renovation. We change the interior but leave the original structure, which retains the characteristics of the aging adult neurons that we want to study.

Like embryonic stem cells, the technique can also allow for converting human skin cells into other cell types by using different transcription factors. Before this technique can be applied to actual humans with neurodegenerative diseases, the researchers still need to find out how much the cells made in their lab match native human motor neurons. Still, its a promising start.

The rest is here:
Researchers Turn Skin Cells into Motor Neurons Without Using ... - Futurism

Nancy Crotti

Researchers have developed tissue nanotransfection, a process for regrowing tissue inside the human body.

Researchers at Ohio State University have developed breakthrough stem cell technology that can regrow tissue inside the human body, rather than in a laboratory.

Their work has implications for critical limb ischemia, brain disorders, and possibly even organ engineering and bone regrowth, according to Chandan Sen, PhD, director of the Center for Regenerative Medicine and Cell-Based Therapies at Ohio State's Wexner Medical Center in Columbus. Sen led the team that developed the technology.

Here's how the process, known as nanotransfection, works: The scientists make synthetic RNA and DNA to match that of the patient. They load it into nanochannels inside tiny needles embedded in a chip and apply the chip to the skin. The needles electrocute about 2% of the cell surface with the patient's nucleic acid. The procedure takes 1/10th of a second, and has been shown to work with up to 98% efficiency.

In experiments on mice, the technology restored blood flow to injured legs by reprogramming the animals' skin cells to become vascular cells. With no other form of treatment, active blood vessels had formed within two weeks, and by the third week, blood flow returned and the legs of the mice were saved.

The researchers also induced strokes in mice and used the chips to grow new brain tissue from the animals' skin and transplant it to their brains. Bodily function damaged by the strokes was restored. The study of the technique, which worked with up to 98% efficiency, was reported in the journal Nature Nanotechnology.

The technology marks an advance over cell regeneration conducted in a laboratory, because those cells mostly underperform or die once transplanted into the body, according to Sen. The researchers use skin cells in their work because, as Sen explained, everybody has some to spare.

"We grow it in you and we move it over to the organ so you have your own cells populating your organ," he said. "It's all coming from you."

The synthetic RNA and DNA reprogram cells in the same way that fetal cells develop different functions to become different body parts, Sen added. The researchers worked on the technology for more than four years, also conducting successful blood flow restoration experiments on pigs. When they begin human trials, their first patients will likely be those whose critical limb ischemic has reached the stage where amputation is the only option.

The scientists' work has generated interest in Europe, Asia, the Middle East, and in the United States. Ohio State will decide where to pursue human trials first, and is searching for industry partners.

"The cost is extremely low and complexity-wise it is extremely low. I see very little barrier to take it to humans," Sen said.

The researchers' work marks another interface between silicon chips and biology. Other applications picked up by manufacturers include DNA sequencing machines, miniaturized diagnostic tests using disposable photonic chips, accurate body monitoring sensors, and brain stimulation probes.

Sen and his team acknowledge that their work will be met with skepticism.

"Whenever you do something that is sort of transformative, you will expect that," Sen said. "Therefore, we actually published this in the most rigorous journal possible. We went through 16 months of criticism and response, after which this was published."

Nancy Crotti is a freelance contributor to MD+DI.

[Image courtesy of THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER]

See the article here:
'Nanotransfection' Turns Animal Skin into Blood Vessels and Brain Cells - Medical Device and Diagnostics Industry

A Decatur elementary student and her mother are recovering following a stem cell transplant in a Cincinnati-area hospital.

It will be six to eight weeks, however, before doctors know whether the membrane Nicole Richey gave her daughter Phoenix is working.

What were praying for is that Phoenix will start producing her own stem cells, Joey Richey said by telephone Thursday.

In January, Phoenix, a fourth-grade student at Chestnut Grove Elementary, was diagnosed with Stevens-Johnsons syndrome, a rare and serious disorder of the skins mucous membranes.

According to the Mayor Clinic, the syndrome is caused by a reaction to medication or infection and begins with flu-like symptoms, which Phoenix had. The disease is followed by painful rashes and blisters that ultimately cause the top layer of skin to die.

The disease affected between 60 and 65 percent of Phoenixs body and damaged her eyes.

During the outpatient procedure, which is called a limbal stem cell transplant, said Joey Richey, surgeons took about 40 percent of the cornea from his wifes left eye and placed it in Phoenixs right eye.

Nicole Richey said she was close to a perfect match, but doctors have put her daughter on immunosuppression therapy to lower the possibility of Phoenix rejecting the stem cells.

I am still having a hard time after my surgery, but were OK, Nicole Richey said.

The procedure took place at St. Elizabeth North Kentucky Surgical Center, and Phoenix will miss about six weeks of school.

Chestnut Grove Principal Luke Bergeson said Phoenix will continue to receive homebound instructional services until she is ready to return to school.

Phoenixs body is still not able to grow its own skin, so she has been fitted with a prokera ring, which is a therapeutic device to protect her eyes. Her left eye is temporarily sewn shut and will be until doctors see how the right eye reacts to the transplant, Joey Richey said.

They are working on one eye at a time, he said.

Phoenix was diagnosed with Stevens-Johnsons syndrome while she was out of school on Christmas break last year. The outer layer of skin started to die and was peeling two days before she was admitted to Huntsville Hospital. On Jan. 12, doctors transferred Phoenix to the burn unit at Childrens Hospital of Birmingham for treatment.

She stayed there a week before being moved to Shriners Hospital for Children in Cincinnati, where she stayed until Feb. 8.

Phoenix missed the remainder of the school term, but she came back to Chestnut Grove when classes started in August.

Read more here:
Decatur elementary student gets stem cells from mother - The Decatur Daily

docent/ShutterstockWhether or not theres a scientific benefit to being baldwell let the follically challenged among us be the judge of thatscientists continue to search for a balding cure. According to UCLA researchers, that isnt completely out of the question. A team, led by Heather Christofk, PhD, and William Lowry, PhD, found a new way to activate the stem cells in the hair follicle to make hair grow. Their findings, published in the journal Nature Cell Biology, may lead to new drugs to promote hair growth or work as a cure for baldness or alopecia (hair loss linked to factors like hormonal imbalance, stress, aging or chemotherapy).

Working at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, the researchers discovered that the metabolism of the stem cells embedded in hair follicles is different from the metabolism of other cells of the skin. When they altered that metabolic pathway in mice, they discovered they could either stop hair growth, or make hair grow rapidly. They did this by first blocking, then increasing, the production of a metabolitelactategenetically.

Before this, no one knew that increasing or decreasing the lactate would have an effect on hair follicle stem cells, says Dr. Lowry, a professor of molecular, cell and developmental biology, as reported on ScienceDaily. Once we saw how altering lactate production in the mice influenced hair growth, it led us to look for potential drugs that could be applied to the skin and have the same effect.

Two drugs in particularknown by the generic designations of RCGD423 and UK5099influenced hair follicle stem cells in distinct ways to promote lactate production. The use of both drugs to promote hair growth are covered by provisional patent applications. However, they are experimental drugs and have been used in preclinical tests only. They wont be ready for prime time until theyve been tested in humans and approved by the Food and Drug Administration as safe and effective. (While youre waiting for a male pattern baldness cure, check out these natural remedies for hair loss.)

So while it may be some time before these drugs are availableif everto treat baldless or alopecia, researchers are optimistic about the future. Through this study, we gained a lot of interesting insight into new ways to activate stem cells, says Aimee Flores, a predoctoral trainee in Lowrys lab and first author of the study. The idea of using drugs to stimulate hair growth through hair follicle stem cells is very promising given how many millions of people, both men and women, deal with hair loss. I think weve only just begun to understand the critical role metabolism plays in hair growth and stem cells in general; Im looking forward to the potential application of these new findings for hair loss and beyond.

This 7-year-old girl living with alopecia will inspire you.

See more here:
This New, Cutting-Edge Treatment Could Be the End of Baldness - Reader's Digest

Press Release

Researchers at Ohio State University Wexner Medical Center uncovered a novel pathway for hair follicular regeneration. Palm tocotrienol complex (EVNol SupraBio) is shown to induce hair follicle growth via protein expression of epidermal E-cadherin dependent beta-catenin - the key signaling molecule for inducing pluripotent stem cells in the adult skin.

In this study (1), male mice with mutated leptin receptor were applied with either 5mg/cm2 palm tocotrienol rich fraction (TRF) (ie. EVNol SupraBio - bioenhanced palm tocotrienol complex, supplied by ExcelVite) or placebo on shaved dorsal skin thrice per week for 21 days and the evaluation of hair growth was recorded by the color of dorsal skin. The mechanism of palm TRF-induced hair growth, the dependency on the loss of E-cadherin and the activation of beta-catenin for hair follicle formation were examined by quantification of gene expressions, immunoprecipitation and immunoblots.

When compared to placebo, palm TRF treated group showed significantly increased number of anagen (ie. cycle of growth) hair follicles, increased fetal characteristics of hair follicular development in the adult skin, increased epidermal keratinocyte proliferation, significant decreased E-cadherin expression that was associated with high translocation of beta-catenin-Tf3, leading to upregulation of gene expressions of Oct4, Sox9, Klf4, c-Myc and Nanog skin-specific pluripotent factors that support hair follicular regeneration. These factors are also known as the Yamanaka Transcription Factors discovered by Dr. Shinya Yamanaka, joint-recipient of the 2012 Nobel Prize in Physiology or Medicine. Prof. Yamanaka discovered that mature cells can be reprogrammed to become pluripotent.

The researchers concluded that palm TRF suppression of epidermal E-cadherin induced beta-catenin and nuclear translocation is the novel pathway that leads to expressions of pluripotent factors and subsequently promotes anagen hair cycling in adult skin.

What we have shown is that Palm TRF can induce hair folliculogenesis, which means that it can enrich the skin stem cell reserves. This novel epidermal pathway of hair follicular regeneration can have widespread impact on skin function including skin aging and repair, says Prof. Chandan Sen, the lead researcher at Ohio State University Wexner Medical Center.

Prior to the above discovery, researchers from University Science Malaysia had reported and patented the unique benefits of tocotrienols (EVNol SupraBio) in supporting hair growth in subjects with on-going hair loss (2).

We are thrilled with this new discovery, especially this novel pathway that affirmed our previous clinical findings for EVNol SupraBio in hair growth, (US Patent No: 7,211,274; Trop. Life Sci. Res. 2010). Taken together this latest study and previous published papers explain the mechanism as to how EVNol SupraBio may help in promoting hair growth in subjects experiencing hair loss, says Bryan See, Business Development Manager, ExcelVite.

Source:

About ExcelVite

ExcelVite Sdn. Bhd., incorporated in Malaysia in 2013, is the leading and largest producer of natural full spectrum tocotrienol / tocopherol complex (EVNol, and EVNol SupraBio), natural mixed-carotene complex (EVTene), phytosterol complex (EVRol), and red palm oil concentrate (EVSpectra) in the world via a patented technology.

ExcelVite is the only tocotrienol producer that operates in accordance to GMP (PIC/S) Guide to Good Manufacturing Practice for Medicinal Products. Its laboratory is accredited with ISO/IEC 17025 accreditation.

EVNol SupraBio is a patented (US Patent No. 6,596,306) self-emulsifying palm tocotrienol complex that ensures optimal tocotrienols oral absorption.

ExcelVite manufactures and markets its products under the tradenames: EVNol, EVNol SupraBio, EVTene, EVRol, and EVSpectra. These branded ingredients are Non-GMO, Kosher and Halal certified. ExcelVite supports the production of certified sustainable palm oil (CSPO) through RSPO Credits.

Websites:www.excelvite.com andwww.tocotrienol.org

The rest is here:
Latest Research Unveiled Novel Pathway For T3 In Hair Follicle Regeneration - Natural Products INSIDER

GUANGZHOU, China, Sept. 5, 2017 /PRNewswire/ -- Chinese Grand Fan Group formally signed the agreement to acquire the French CICABEL brand on September 4th. Grand Fan Group is openly optimistic about CICABEL's technology and development prospects, while the investment into the French brand represents the first step in the execution of the strategy behind the group's entry into the skin care market. The signing ceremony took place in France.

Santinov is a 130-year-old French traditional pharmaceutical manufacturer founded in 1887. Santinov created and launched the CICABEL Mask, a three-step revitalizing and hydration face mask set using stem cells as the principal component, following years of research and development on the back of strong technological competence. At variance with traditional skin care products, the set is expected to become a disruptor and transform the public's expectations from the beauty industry.

A Grand Fan Group executive said "By adopting the management and operations model commonly deployed by international brands, we put in place partnerships with several leading international beauty and health brands based on our own brand, achieving a diversified brand scenario as well as access to advanced technology R&D. These moves will serve to offer more and better choices to consumers."

With the enhancement of the general public's awareness of skin care, traditional skin care products no longer meet the basic expectations and needs of consumers. Brands with an ill-defined image or a hodge-podge of seemingly unrelated products, uneven quality, inadequate supervision and other issues have led the industry to be subject to a high level of criticism. To add insult to injury, most traditional skin care products actually do little for the skin. In line with accepted biotechnology and medical standards, the CICABEL Mask is expected to reverse the perception.

Through the activation of skin stem cells, the mask provides nutrition that penetrates deep into the dermis and promotes the regeneration of new cells, delivering an in-depthreplenishment effect. Put in another way, CICABEL uses the body's own multifunctional cells to achieve a new level of skin beauty. The CICABEL Mask from France is expectedto become the "Terminator" of traditional masks available in the market.

CICABEL will formally go on sale in China soon, with plans for roll outs in several global markets shortly thereafter.

Contact: +86-400-639-1958, rel="nofollow">hantao@1958difo.com

View original content with multimedia:http://www.prnewswire.com/news-releases/china-based-grand-fan-group-acquires-leading-french-skincare-brand-300513684.html

SOURCE CICABEL

View post:
China-based Grand Fan Group acquires leading French skincare brand - Markets Insider

Microneedling has quickly become one of the most popular skin rejuvenation treatments. If youre considering trying it, here is what you need to know.

Microneedling, also called collagen-induction therapy, uses small needles that pierce the outermost layer of skin to create tiny microchannels. These microchannels help stimulate the production of collagen and elastin within the skin. They also promote new capillaries.

This can lead to an improved skin texture, reduction of acne or other scarring and help with discoloration, such as brown spots caused by sun damage. Microneedling may be combined with platelet-rich plasma, stem cells, or pure hyaluronic acid to enhance results further.

Microneedling can also be used on the scalp to help stimulate hair rejuvenation.

Prior to your first microneedling session, you will be asked to avoid sun exposure for at least 24 hours. Some doctors will tell you to avoid blood-thinning medications and herbal supplements like aspirin, ibuprofen and St. Johns wort to reduce bruising.

Each microneedling session takes about 20 to 30 minutes. First, your face will be cleansed and a numbing cream will be applied. Multiple treatment sessions, spaced a few weeks apart, are recommended. Most doctors recommend three to six treatments but many will notice an improvement in the tone and texture of their skin after just one treatment.

Immediately after your microneedling session, you will likely notice some redness that can last for several days. In my practice, we recommend that patients do not touch their face for at least four hours after treatment and do not apply anything to the face for 24 hours. It is crucial to avoid sun exposure for three days after the procedure.

You should avoid strenuous activity and exercise for the first 12 hours after treatment to prevent redness and bruising. For the first three days after treatment, you should use a gentle non-foaming cleanser, a barrier repair moisturizer, and a physical SPF. If swelling or bruising are a concern, you can take arnica supplements both before and after treatment to help minimize these side effects.

Once any redness or swelling diminishes, you should notice an immediate improvement in the way your skin looks and feels. Over the next several weeks, your skins appearance should continue to improve.

Read the rest here:
What is microneedling and why is the skin treatment so popular? - Miami Herald

Chemical changes in the eye that can lead to blindness have been identified by scientists, a conference will hear tomorrow (Tuesday 5 September).

Their findings aid understanding of a genetic condition that causes sight loss for one in 3,000 people in the UK.

They will be presented at the Eye Development and Degeneration 2017 conference in Edinburgh.

Eye condition

Scientists examined how changes in a gene known as RPGR damage eye cells to cause a disorder known as X-linked retinitis pigmentosa.

The condition is incurable and affects night and peripheral vision before gradually causing blindness in middle age.

Skin samples

A team led by Edinburgh researchers took skin samples from two patients and transformed stem cells which can change into any cell type into light-sensing eye cells known as photoreceptors.

They compared these with cells from healthy relatives of the patients.

Photoreceptors which decay in retinitis pigmentosa patients differed in their fundamental structure when compared with those from family members.

Key molecules

Follow-up studies in mice identified key molecules that interact with RPGR to maintain the structure of photoreceptors.

When RPGR is flawed, the structure is compromised and photoreceptors cannot function correctly, leading to sight loss.

The study is published in the journal Nature Communications and was carried out at the University of Edinburgh's Medical Research Council Centre for Regenerative Medicine.

It was funded by the Wellcome Trust and the charity Retinitis Pigmentosa Fighting Blindness.

"By furthering our understanding of the RPGR gene and its effects on photoreceptor cells, we hope our findings bring us closer to developing a possible treatment for this devastating disease," says Dr Roly Megaw of the Medical Research Council Institute for Genetics and Molecular Medicine.

Explore further: New trial for blindness rewrites the genetic code

See the article here:
Gene study sheds light on middle-age sight loss - Medical Xpress

Monkeys with Parkinsons disease symptoms show significant improvement over two years after being transplanted neurons prepared from human induced pluropontent stem cells, scientists at the Center for iPS Cell Research and Application (CiRA), Kyoto University, report. One of the last steps before treating patients with an experimental cell therapy for the brain is confirmation that the therapy works in monkeys.

Parkinsons disease degenerates a specific type of cells in the brain known as dopaminergic (DA) neurons. It has been reported that when symptoms are first detected, a patient will have already lost more than half of his or her DA neurons.

Several studies have shown the transplantation of DA neurons made from fetal cells can mitigate the disease.

The use of fetal tissues is controversial, however. On the other hand, iPS cells can be made from blood or skin.

Our research has shown that DA neurons made from iPS cells are just as good as DA neurons made from fetal midbrain. Because iPS cells are easy to obtain, we can standardize them to only use the best iPS cells for therapy,

said Professor Jun Takahashi, a neurosurgeon specializing in Parkinsons disease, who plans to use DA neurons made from iPS cells to treat patients.

To test the safety and effectiveness of DA neurons made from human iPS cells, Tetsuhiro Kikuchi, a neurosurgeon working in the Takahashi lab, transplanted the cells into the brains of monkeys.

We made DA neurons from different iPS cells lines. Some were made with iPS cells from healthy donors. Others were made from Parkinsons disease patients,

said Kikuchi, who added that the differentiation method used to convert iPS cells into neurons is suitable for clinical trials.

It is generally assumed that the outcome of a cell therapy will depend on the number of transplanted cells that survive, but Kikuchi found this was not the case. More important than the number of cells was the quality of the cells.

Each animal received cells prepared from a different iPS cell donor. We found the quality of donor cells had a large effect on the DA neuron survival, Kikuchi said.

To understand why, he looked for genes that showed different expression levels, finding 11 genes that could mark the quality of the progenitors. One of those genes was Dlk1.

Dlk1 is one of the predictive markers of cell quality for DA neurons made from embryonic stem cells and transplanted into rat. We found Dlk1 in DA neurons transplanted into monkey. We are investigating Dlk1 to evaluate the quality of the cells for clinical applications.

Another feature of the study that is expected to extend to clinical study is the method used to evaluate cell survival in the host brains. The study demonstrated that magnetic resonance imaging (MRI) and position electron tomography (PET) are options for evaluating the patient post surgery.

MRI and PET are non-invasive imaging modalities. Following cell transplantation, we must regularly observe the patient. A non-invasive method is preferred,

said Takahashi.

The group is hopeful that it can begin recruiting patients for this iPS cell-based therapy before the end of next year. The study is the teams answer to bring iPS cells to clinical settings, said Takahashi.

Tetsuhiro Kikuchi, Asuka Morizane, Daisuke Doi, Hiroaki Magotani, Hirotaka Onoe, Takuya Hayashi, Hiroshi Mizuma, Sayuki Takara, Ryosuke Takahashi, Haruhisa Inoue, Satoshi Morita, Michio Yamamoto, Keisuke Okita, Masato Nakagawa, Malin Parmar, Jun TakahashiHuman iPS cell-derived dopaminergic neurons function in a primate Parkinsons disease modelNature, 2017; 548 (7669): 592 DOI: 10.1038/nature23664

Image: Annie Cavanagh / Wellcome Images

Continue reading here:
iPS Cell-based Neuron Therapy Benefits Monkeys With Parkinson's - ReliaWire

Microneedling has quickly become one of the most popular skin rejuvenation treatments. If youre considering trying it, here is what you need to know.

Microneedling, also called collagen-induction therapy, uses small needles that pierce the outermost layer of skin to create tiny microchannels. These microchannels help stimulate the production of collagen and elastin within the skin. They also promote new capillaries.

This can lead to an improved skin texture, reduction of acne or other scarring and help with discoloration, such as brown spots caused by sun damage. Microneedling may be combined with platelet-rich plasma, stem cells, or pure hyaluronic acid to enhance results further.

Microneedling can also be used on the scalp to help stimulate hair rejuvenation.

Prior to your first microneedling session, you will be asked to avoid sun exposure for at least 24 hours. Some doctors will tell you to avoid blood-thinning medications and herbal supplements like aspirin, ibuprofen, and St. Johns wort to reduce bruising.

Each microneedling session takes about 20 to 30 minutes. First, your face will be cleansed and a numbing cream will be applied. Multiple treatment sessions, spaced a few weeks apart, are recommended. Most doctors recommend three to six treatments but many will notice an improvement in the tone and texture of their skin after just one treatment.

Immediately after your microneedling session, you will likely notice some redness that can last for several days. In my practice, we recommend that patients do not touch their face for at least four hours after treatment and not to apply anything to the face for 24 hours. It is crucial to avoid sun exposure for three days after the procedure.

You should avoid strenuous activity and exercise for the first 12 hours after treatment to prevent redness and bruising. For the first three days after treatment, you should use a gentle non-foaming cleanser, a barrier repair moisturizer, and a physical SPF. If swelling or bruising are a concern, you can take arnica supplements both before and after treatment to help minimize these side effects.

Once any redness or swelling diminishes, you should notice an immediate improvement in the way your skin looks and feels. Over the next several weeks, your skins appearance should continue to improve.

Read the original here:
Here's What You Need to Know about Microneedling - Miami Herald

LONDON (Reuters)Scientists have successfully used reprogrammed stem cells to restore functioning brain cells in monkeys, raising hopes the technique could be used in future to help patients with Parkinsons disease.

Since Parkinsons is caused by a lack of dopamine made by brain cells, researchers have long hoped to use stem cells to restore normal production of the neurotransmitter chemical.

Now, for the first time, Japanese researchers have shown that human induced pluripotent stem cells (iPS) can be administered safely and effectively to treat primates with symptoms of the debilitating disease.

So-called iPS cells are made by removing mature cells from an individualoften from the skinand reprogramming them to behave like embryonic stem cells. They can then be coaxed into dopamine-producing brain cells.

The scientists from Kyoto University, a world-leader in iPS technology, said their experiment indicated that this approach could potentially be used for the clinical treatment of human patients with Parkinsons.

In addition to boosting dopamine production, the tests showed improved movement in affected monkeys and no tumors in their brains for at least two years.

The human iPS cells used in the experiment worked whether they came from healthy individuals or Parkinsons disease patients, the Japanese team reported in the journal Nature on Wednesday.

This is extremely promising research demonstrating that a safe and highly effective cell therapy for Parkinsons can be produced in the lab, said Tilo Kunath of the MRC Centre for Regenerative Medicine, University of Edinburgh, who was not involved in the research.

The next step will be to test the treatment in a first-in-human clinical trial, which Jun Takahashi of Kyoto University told Reuters he hoped to start by the end of 2018.

Any widespread use of the new therapy is still many years away, but the research has significantly reduced previous uncertainties about iPS-derived cell grafts.

The fact that this research uses iPS cells rather human embryonic stem cells means the treatment would be acceptable in countries such as Ireland and much of Latin America, where embryonic cells are banned.

Excitement about the promise of stem cells has led to hundreds of medical centers springing up around the world claiming to be able to repair damaged tissue in conditions such as multiple sclerosis and Parkinsons.

While some treatments for cancer and skin grafts have been approved by regulators, many other potential therapies are only in early-stage development, prompting a warning last month by health experts about the dangers of stem-cell tourism.

Link:
Human Stem Cells Fight Parkinson's Disease in Monkeys - Scientific American

| Marlowe Hood |

PARIS (AFP) Lab monkeys with Parkinsons symptoms regained significant mobility after neurons made from human stem cells were inserted into their brains, researchers reported Wednesday in a study hailed as groundbreaking.

The promising results were presented as the last step before human clinical trials, perhaps as early as next year, the studys senior author, Jun Takahashi, a professor at Kyoto University, told AFP.

Parkinsons is a degenerative disease that erodes motor functions. Typical symptoms include shaking, rigidity and difficulty walking. In advanced stages, depression, anxiety and dementia are also common.

Worldwide, about 10 million people are afflicted with the disease, according to the Parkinsons Disease Foundation.

Earlier experiments had shown improvements in patients treated with stem cells taken from human foetal tissue and likewise coaxed into the dopamine-producing brain cells that are attacked by Parkinsons.

Dopamine is a naturally occurring chemical that plays several key roles in the brain and body.

But the use of foetal tissue is fraught with practical and ethical problems.

So Takahashi and his colleagues, in a medical first, substituted so-called induced pluripotent stem cells (iPSCs), which can be easily made from human skin or blood. Within a year, some monkeys who had could barely stand up gradually recovered mobility.

They became more active, moving more rapidly and more smoothly, Takahashi said by email. Animals that had taken to just sitting start walking around in the cage.

These findings are strong evidence that human iPSC-derived dopaminergic neurons can be clinically applicable to treat Parkinsons patients, he said.

Experts not involved in the research described the results as encouraging.

The treatment, if proven viable, has the potential to reverse Parkinsons by replacing the dopamine cells that have been lost a groundbreaking feat, said David Dexter, deputy research director at Parkinsons UK.

Not only did the new cells survive but they also integrated with the existing neuronal network, he said.

Neurons made from foetal tissue grafted into brains have been known to survive for more than a decade, and the researchers said they expected those derived from iPSCs to last just as long.

Tilo Kunath, Parkinsons Senior Research Fellow at the University of Edinburgh, said the outcome was extremely promising, and highlighted the advantage of avoiding stem cells extracted from human foetal tissue.

It means that this therapy can be used in any country worldwide, including Ireland and most of South America, where medical use of human embryonic stem cells is banned.

The results, reported in the journal Nature, were not the same for the dozen monkeys in the experiment, each of which received donor neurons from a different person.

Some were made with cells from healthy donors, while others were made from Parkinsons disease patients, said lead author Tetsuhiro Kikuchi, also from Kyoto University.

See original here:
Study shows human stem cells restore mobility in Parkinson's monkeys - Borneo Bulletin Online

Parkinsons stem cell breakthrough

Miodrag Stojkovic/Science Photo Library

By Helen Thomson

MONKEYS with a Parkinsons-like disease have been successfully treated with stem cells that improved their movement for up to two years after transplant. A similar trial is now being prepared for people.

Parkinsons destroys dopamine-producing cells in the brain, leading to tremors and difficulty moving. Previous experiments using stem cells from embryos have shown promise in replacing lost cells, but the use of these is controversial.

Jun Takahashi at Kyoto University, Japan, and colleagues wondered whether they could treat monkeys with a disease like Parkinsons using induced pluripotent stem cells, which are made by coaxing blood or skin cells into becoming stem cells.

Advertisement

The team generated stem cells from three people with Parkinsons and four without the disease. They then transformed these into dopamine-producing brain cells.

All the monkeys who received injections of these cells showed a 40 to 55 per cent improvement in their movements, matching results from previous experiments with embryonic stem cells. Monkeys who had a control injection minus the cells didnt improve (Nature, DOI: 10.1038/nature23664).

Stem cells from people with and without Parkinsons were equally effective. The monkeys became more active and showed less tremor, says Takahashi. Their movements became smoother.

After the transplant, the monkeys were given immunosuppressive drugs to prevent the new cells from being rejected and observed for up to two years. No serious side effects appeared during this time.

This study shows that the stem cells behave as you would like them to and they appear safe, says Roger Barker of the University of Cambridge. All of which gives one greater confidence in moving to human studies.

This article appeared in print under the headline Parkinsons stem cell breakthrough

More on these topics:

Original post:
Human blood and skin cells used to treat Parkinson's in monkeys - New Scientist

This month MyChelle will be available at Kohl's stores and Kohls.com with a key assortment of cleansers, exfoliators, serums, moisturizers, and sun protection, and a focus on their innovative, professional-level ingredient pillars of Vitamin C and Vitamin Aunmatched in the natural product channel. The brand's award-winning products are formulated with bioactive, clinically-proven ingredients that won't compromise personal health or the wellbeing of the environment.

MyChelle Ingredient Integrity and Transparency

Since its founding in 2000, MyChelle has been committed to full transparency when it comes to the botanicals and high-performance ingredients it uses in its products. The company is a proud founding member of the EWG VERIFIED: For Your Health program to help consumers quickly and easily identify personal care products that are formulated without potentially hazardous ingredients, fully disclose all ingredients, and are created following good manufacturing practices.

The MyChelle Beauty Key 3

Formulated with the top 3 dermatologist-recommended ingredients, the MyChelle Beauty Key 3 integrates a powerful combination of peptides, plant stem cells, antioxidants, and retinoids to perfect, correct, and protect all skin types.

1. C the Difference with L-Ascorbic Acid

The only active form of Vitamin C, L-Ascorbic Acid enhances skin's natural renewal process, protects skin against environmental damage, reduces the appearance of dark spots, and helps to improve the look of acne scarring. The MyChelle Perfect C system includes Perfect C PRO Serum, Perfect C PRO Speed Peel, Perfect C Radiance Lotion, and Perfect C Eye Cream.

2. Remarkable Results with Retinal

The most potent non-prescription form of Vitamin A, Retinal promotes healthy skin renewal and helps minimize the appearance of fine lines, wrinkles, and hyperpigmentation by accelerating cellular turnover. The MyChelle Remarkable Retinal system includes Remarkable Retinal Serum, Remarkable Retinal Night Cream, and Remarkable Retinal Eye Cream.

3. We've Got You Covered with 100% Mineral-Based Sun Protection

Titanium Dioxide- and/or Zinc Oxide-based formulas prevent both UVA and UVB damage with a safe and highly effective physical layer of protection. The MyChelle Sun Care collection includes Sun Shield Clear Stick SPF 50, Sun Shield Liquid Tint SPF 50 - Nude, and Sun Shield SPF 28 Unscented.

For updated MyChelle company news, events, and retail promotions, follow MyChelle on Facebook, Twitter, and Instagram. Visit the MyChelle blog for expert skin care advice.

About MyChelle Dermaceuticals

Founded in 2000, MyChelle was the natural industry's first to use anti-aging peptides, plant stem cells, and clinically proven dermatological ingredients. Our 360-degree approach to beauty provides clean, conscious, and comprehensive products that are bioactive and ethically sourced.

View original content with multimedia:http://www.prnewswire.com/news-releases/natural-skin-care-authority-mychelle-launches-at-nationwide-department-store-300511352.html

SOURCE MyChelle Dermaceuticals

http://www.mychelle.com

More:
Natural Skin Care Authority MyChelle Launches at Nationwide Department Store - PR Newswire (press release)

[FEATURED] This month saw skincare brand Nikel Cosmetics hosting a series of educational talks around the country with Leigh-Anne Williams

August is Womens Month and Nikel Cosmetics kicked off celebrations with a series of skincare events, hosted by TV presenter and local celeb,Leigh-Anne Williams. Thetour took SA by storm, starting in Cape Town on 5 August, moving toDurban on the 12th,andfinishing off in Johannesburg on 19 August.

Women came out in droves tolearnabouttheir skin types and experience the exclusive Nikel skincare brand. Leigh-Anne also shared her skincare journey, her experience with the products and their efficacy.

Tea Visek, Director: Cos Chem (the distributor of Nikel Cosmetics in South Africa), helped answer questions about skincare concerns raisedby the members of the audiences.She also explainedin depth the natural ingredients in the productsand how to customise the rangeto ensure maximum efficiency for individualised skincare.

Different skin types and problems require different skin regimens, saidTea. For that reason, its very important to choose the right combination of products for you, so that you canget the bestresults.

For example, one of the most common skin problems weve encountered whentalking to our customers is oily skin with dehydrated patches, often the result of external influences on the skin. Dry areas appear on parts of the face, while the rest remains oily. In these cases, what is needed is targeted care that restores hydration without clogging the pores oradding oil to already oily skin.

Tea recommends the Nikel Evening Primrose Oil, whichcanbe appliedtothe dry areas of the face and offers intense hydration. This should befollowed by the Nikelhidris Face Cream for additional moisturisingcare.

Of course, before starting any skincare routine, you should make sure theskin is clean. Try the mild Nikel Cleansing Milk with Immortelly, which doesntdry out the skin. It removes make-up and other impurities from the skin and you dont have to rinse it off with water.

Finally, to refresh the face at any hour of the day, Tea recommends spritzingNikel Alpine Rose Tonic with stem cells on the face and leaving itto dry naturally.

To find out more about different skin problems and their solutions, visit NikelsOnline Beauty Consultant.

More here:
Your skincare problems solved - DestinyConnect

It is a question people have been asking forwell-- ages. Is there a way to turn back the aging process in people?

For centuries, people have been looking for a fountain of youth. The idea is that if you find a magical fountain, and drink from its waters, you will not age.

Spanish explorer Juan Ponce de Len searched for waters with magical powers in the early 1500s. But what he found instead is the American state of Florida.

Researchers in New York did not find an actual fountain of youth, but they may have found a way to turn back the aging process. It appears the answer may be hidden right between your eyes, in an area called the hypothalamus.

The hypothalamus is part of your brain. It controls important activities within the body. They include growth, reproduction and the way we process food.

Researchers at New Yorks Albert Einstein College of Medicine found that hypothalamus neural stem cells also influence how fast aging takes place in the body.

What are stem cells? They are simple cells that can develop into specialized cells, like blood or skin cells. Stem cells can also repair damaged tissues and organs.

Dongsheng Cai is a professor at the Albert Einstein College of Medicine. He was the lead researcher in a study on aging in mice. He and his team reported their findings in the journal Nature.

Cai explains what they found.

"Aging speed is controlled, can be controlled by a particular place in the body, which is the hypothalamus. And it can be controlled by a particular type of cells, which are hypothalamus stem cells. I think these findings are quite interesting, potentially even remarkable."

He adds that when the hypothalamus starts aging, so does the body.

"So when hypothalamus function is in decline, particularly the loss of hypothalamus stem cells, and this protection against the aging development is lost, it eventually leads to aging."

Using this information, the researchers began trying to activate, or energize, the hypothalamus in laboratory mice. They did this by injecting the animals with stem cells.

Later, the researchers examined tissues and tested for changes in behavior. They looked for changes in the strength and coordination of the animals muscles. They also studied the social behavior and cognitive ability of the mice.

The researchers say the results show that the treatment slowed aging in the animals.

Cai says injecting middle-aged mice with stem cells from younger mice helped the older animals live longer.

"When we injected the hypothalamus stem cells, which were derived from young mice, we injected them to the middle-aged mice and that was, in fact, to slow down aging. So the mouse aged slowly and they also have increased their lifespan, which is longevity."

But these results were just from studying mice in a laboratory. If the mice can live longer, does that mean people could have longer lives? The next step is to see if the anti-aging effects also work in human beings.

"If we can translate what we have seen in animals to humans, I think humans, they can function better during later ages, later stage of aging."

Cai and his team say their studies may have other benefits. They say the findings could lead to new ways to help doctors identify and treat any number of age-related health issues.

Im Anne Ball.

Kevin Enochs reported on this story for VOANews.com. Anne Ball adapted this story for Learning English. George Grow was the editor.

We want to hear from you. Write to us in the Comments Section.

______________________________________________________________

Now, test your understanding with this short quiz.

______________________________________________________________

fountain n. a device or structure that sends a stream of water into the air in a garden, park, etc

neural adj. of, relating to, or involving a nerve or the nervous system

remarkable adj. unusual or surprising : likely to be noticed

function n. the job or duty of a person

coordination n. the process of organizing people or groups so that they work together properly and well

cognitive adj. of, relating to, or involving conscious mental activities (such as thinking, understanding, learning, and remembering)

benefit n. a good or helpful result or effect

Continue reading here:
Researchers Use Brain Cells to Control Aging in Mice - VOA Learning English

(Reuters) - The U.S. Food and Drug Administration (FDA) is stepping up efforts to better regulate an emerging field of medicine that holds significant promise for curing some of the most troubling diseases by using the body's own cells.

A small number of "unscrupulous actors" have seized on the promise of regenerative medicine and stem cell therapies to mislead patients based on unproven, and in some cases, dangerously dubious products, the FDA said on Monday. (bit.ly/2iB4Xls)

Regenerative medicine makes use of human cells or tissues that are engineered or taken from donors. Health regulators have approved some types of stem cell transplants that mainly use blood and skin stem cells after clinical trials found they could treat certain types of cancer and grow skin grafts for burn victims.

But many potential therapies are still in the earliest stages of development. These therapies are sometimes advertised with the promise of a cure, but they often have scant evidence backing their efficacy or safety.

The FDA said it had taken steps to tackle the problem of some "troubling products" being marketed in Florida and California.

Federal officials on Friday seized from San Diego-based StemImmune Inc vials containing hundreds of doses of a vaccine reserved only for people at high risk for smallpox, the FDA said. (bit.ly/2wC1DMU)

The seizure followed recent FDA inspections that confirmed the vaccine was used to create an unapproved stem cell product, which was then given to cancer patients, the agency added.

The FDA also sent a warning letter to a Sunrise, Florida-based clinic for marketing stem cell products without regulatory approval and for major deviations from current good manufacturing practices. (bit.ly/2giGlx9)

The health regulator will present a new policy framework this fall that will more clearly detail the "rules of the road" for regenerative medicine, FDA Commissioner Scott Gottlieb, a cancer survivor, said in a statement.

Reporting by Natalie Grover in Bengaluru; Additional reporting by Tamara Mathias; Editing by Sai Sachin Ravikumar

Continue reading here:
FDA steps up scrutiny of stem cell therapies - Reuters